Literature DB >> 30057376

Takotsubo syndrome and chronic kidney disease: a deadly duet in long-term follow-up.

Małgorzata Zalewska-Adamiec, Jolanta Małyszko, Hanna Bachórzewska-Gajewska, Anna Tomaszuk-Kazberuk, Marcin Kożuch, Paweł Kralisz, Sławomir Dobrzycki.   

Abstract

Introduction The prognosis of takotsubo syndrome (TTS) was recognized as benign. However, patients with TTS and chronic kidney disease (CKD) more often experience severe complications in the acute phase of the disease, particularly sudden cardiac arrest. Objectives We aimed to assess the impact of CKD on early and long-term outcomes, including mortality, among 95 patients with TTS. Patients and methods All patients underwent coronary angiography. Clinical, biochemical, and other medical data were recorded. Estimated glomerular filtration rate was assessed using the CKD‑EPI formula. Results CKD was diagnosed in 32% of the patients. Contrast‑induced acute kidney injury (CI‑AKI) was not reported in any of the patients. Patients with CKD were older but had a lower prevalence of positive cardiovascular family history as well as higher creatine kinase activity and concentrations of inflammatory parameters. During hospitalization, sudden cardiac arrest was more common in CKD patients. In‑hospital, 1‑year, and long‑term mortality rates were the highest in CKD patients, reaching 33.3% in long‑term follow‑up. Predictors of death in a multivariate analysis were body mass index, ejection fraction, and serum creatinine concentrations. Conclusions CKD is a novel and still underestimated risk factor for TTS. It may trigger TTS but, more importantly, it adversely affects the outcomes. Thus, it is important to assess kidney function in all patients with TTS to evaluate the risk of morbidity and mortality in follow‑up, as well as to adjust drug doses and implement preventive measures to avoid CI‑AKI when coronary angiography or contrast‑enhanced computed tomography is performed.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30057376     DOI: 10.20452/pamw.4309

Source DB:  PubMed          Journal:  Pol Arch Intern Med        ISSN: 0032-3772


  4 in total

1.  The GRACE Scale in the Prognosis of Patients with Takotsubo Syndrome.

Authors:  Malgorzata Zalewska-Adamiec; Lukasz Kuzma; Slawomir Dobrzycki; Hanna Bachorzewska-Gajewska
Journal:  J Interv Cardiol       Date:  2020-04-24       Impact factor: 2.279

2.  Neutrophile-Lymphocyte Ratio and Outcome in Takotsubo Syndrome.

Authors:  David Zweiker; Edita Pogran; Laura Gargiulo; Ahmed Abd El-Razek; Ivan Lechner; Ivan Vosko; Stefan Rechberger; Heiko Bugger; Günter Christ; Diana Bonderman; Evelyn Kunschitz; Clara Czedik-Eysenberg; Antonia Roithinger; Valerie Weihs; Christoph C Kaufmann; Andreas Zirlik; Axel Bauer; Bernhard Metzler; Thomas Lambert; Clemens Steinwender; Kurt Huber
Journal:  Biology (Basel)       Date:  2022-08-01

3.  Takotsubo syndrome - fatal prognosis of patients with low body mass index in 5-year follow-up.

Authors:  Malgorzata Zalewska-Adamiec; Jolanta Malyszko; Hanna Bachórzewska-Gajewska; Anna Tomaszuk-Kazberuk; Sławomir J Dobrzycki
Journal:  Arch Med Sci       Date:  2019-08-08       Impact factor: 3.318

4.  The outcome of patients with myocardial infarction with non-obstructive coronary arteries (MINOCA) and impaired kidney function: a 3-year observational study.

Authors:  Malgorzata Zalewska-Adamiec; Jolanta Malyszko; Ewelina Grodzka; Lukasz Kuzma; Slawomir Dobrzycki; Hanna Bachorzewska-Gajewska
Journal:  Int Urol Nephrol       Date:  2021-02-18       Impact factor: 2.370

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.